GlassScriptPhysician profile
Rohit Surasani Reddy
NPI 1568023372
$5,062.85
in general payments reported to CMS, 2019-2025
13 companies · $3,220 in 2025
The $3,220 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $98.72 · 2021: $309 · 2022: $115 · 2023: $881 · 2024: $439 · 2025: $3,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $1,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $1,539.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $3,205.61 | 2025 | Focal One |
| Medtronic, INC. | $575.07 | 2023-2024 | Interstim |
| Boston Scientific Corporation | $367.72 | 2022-2024 | Lithovue, Rezum Generator |
| Coloplast Corp | $283.37 | 2023-2024 | Porges Coloplast, Titan |
| Teleflex LLC | $136.13 | 2021 | |
| Baxter Healthcare | $122.32 | 2024 | Tisseel |
| Palette Life Sciences, INC. | $98.72 | 2020 | |
| Hollister Incorporated | $90.85 | 2021 | |
| Astellas Pharma US INC | $82.28 | 2021 | |
| Photocure INC | $40.96 | 2023 | Cysview |
| Janssen Biotech, INC. | $27.21 | 2023 | Erleada |
| Urogen Pharma, INC. | $18.40 | 2024 | |
| Sumitomo Pharma America, INC. | $14.21 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.